Johnson & Johnson ketamine-derived nasal spray gets FDA approval for depression, but JNJ stock dips on earnings
Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven’t responded to oral antidepressants. On Tuesday, the Food and Drug Administration (FDA) ...
Snow-induced roof collapse won’t derail Mobile Civic Center demolition schedule
The roof of the Mobile Civic Center collapsed Wednesday, two to three weeks ahead of schedule, after the unprecedented weight of nearly 7.5 inches of snow proved too much for the remnants of the ...